[Adverse reactions of GLP-1 inhibitors when used to treat obesity in non-diabetic patients]. [PDF]
Aten PrimariaBarceló Colomer ME, Fernández Liz E.
europepmc +1 more source
Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance. [PDF]
Cancers (Basel)Pina-Cabral T +10 more
europepmc +1 more source
Lysozyme Functionalized Alginate-Chitosan Beads and Films for Different Release Applications. [PDF]
GelsMoutinho B +4 more
europepmc +1 more source
Long-term mortality and predictive score performance in Brazilian atherosclerotic renovascular disease patients. [PDF]
J Bras NefrolSalome JG +9 more
europepmc +1 more source
Judicialization of Zolgensma in the Ministry of Health: costs and clinical profile of patients. [PDF]
Rev Saude PublicaKretzschmar AKM +3 more
europepmc +1 more source
[Use of disease-modifying therapies in spinal muscular atrophy 5q in Mexico]. [PDF]
Rev Med Inst Mex Seguro SocMeza-Cano ME, Molina-Castillo C.
europepmc +1 more source
La cerámica de botica en las farmacias de Sevilla; en los museos municipales de Jerez de la Fra. y El Puerto de Santa María; en el Museo de Historia de la Farmacia de la Universidad de Granada, y en la farmacia antigua del Colegio Oficial de Farmacéuticos de Huelva [PDF]
, 2011 Moreno Toral, Esteban +2 more
core
Unveiling the intricate dynamics of the interplay between triple-negative breast cancer cells and the blood-brain barrier endothelium. [PDF]
Acta Neuropathol CommunGarcia AR +5 more
europepmc +1 more source
[Extension of the term of validity of pharmaceutical patents by lawsuits: effects on centralized procurement and the private market]. [PDF]
Cad Saude PublicaParanhos J +4 more
europepmc +1 more source